Baekje Shenzhou: Phase 3 RATIONALE 315 trial of tirelizumab combined with chemotherapy for resectable NSCLC achieved its primary endpoint of MPR and EFS
芊芊551
发表于 2023-10-22 12:11:47
273
0
0
On October 22nd, the Baekje Shenzhou official announced that the Phase 3 clinical trial of Tirelizumab combined with chemotherapy for resectable NSCLC achieved its primary endpoints of MPR and EFS in the Phase 3 RATIONALE 315 trial. The Phase 3 clinical trial achieved its dual primary endpoints: primary pathological response (MPR) evaluated by blind independent pathological review (BIPR) and event free survival (EFS) evaluated by blind independent center review (BICR). Compared with placebo combined chemotherapy as a neoadjuvant treatment and receiving placebo treatment after surgery, resectable stage II or IIIA non-small cell lung cancer (NSCLC) patients who received tirolizumab combined chemotherapy before surgery and tirolizumab monotherapy after surgery showed statistically significant and clinically significant improvements. After neoadjuvant therapy, the combination of tirelizumab and chemotherapy also showed statistically significant improvement in pathological complete response (pCR) in the key secondary endpoint compared to chemotherapy alone.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Tesla China's latest statement: not true! Trump suddenly spreads big news! Has Musk become a big winner again?
- Johnson&Johnson China reported layoffs! Layoff employees: Surgical department has the highest number of layoffs
- The Nasdaq China Golden Dragon Index closed up 1.71%, with most popular Chinese concept stocks rising
- The Nasdaq China Golden Dragon Index closed up 1.71%, with most popular Chinese concept stocks rising
- Yum China repurchases 50000 shares and pays approximately $2.4 million
- FSD authorizes SAIC to layout Robotaxi? Tesla China: Never Connected
- Starbucks responds to rumors of 'considering selling shares in China business': committed to developing in China and striving to find the best growth path
- Starbucks responds to rumors of considering selling equity in its China business: committed to long-term development in the Chinese market and striving to find the best growth path
- The Nasdaq China Golden Dragon Index closed down 1%, with most popular Chinese concept stocks falling
- The Nasdaq China Golden Dragon Index closed down 1.37%, while Kingsoft Cloud rose nearly 25%
-
知名做空机构香橼研究(Citron Research)周四(11月21日)在社交媒体平台X上发布消息称,该公司已决定做空“比特币大户”微策略(Microstrategy)这家公司,并认为该公司已经将自己变身成为一家比特币投资基金 ...
- caffycat
- 昨天 11:18
- 支持
- 反对
- 回复
- 收藏
-
每经AI快讯,11月20日,文远知行宣布旗下自动驾驶环卫车S6与无人扫路机S1分别在新加坡滨海湾海岸大道与滨海艺术中心正式投入运营。据介绍,这是新加坡首个商业化运营的自动驾驶环卫项目。 ...
- star8699
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
上证报中国证券网讯(记者王子霖)11月20日,斗鱼发布2024年第三季度未经审计的财务报告。本季度斗鱼依托丰富的游戏内容生态,充分发挥主播资源和新业务潜力,持续为用户提供高质量的直播内容及游戏服务,进一步 ...
- goodfriendboy
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
人民网北京11月22日电 (记者栗翘楚、任妍)2024广州车展,在新能源汽车占据“半壁江山”的同时,正加速向智能网联新能源汽车全面过渡,随着“端到端”成为新宠,智能驾驶解决方案成为本届广州车展各大车企竞 ...
- 3233340
- 昨天 17:06
- 支持
- 反对
- 回复
- 收藏